There was neither a rise in hemoglobin levels nor a fall in plasma or urinary KIM-1 levels, suggesting that these agents may not be beneficial in ADTKD. This evidence concerns the gene HAVCR1 and autosomal dominant medullary cystic kidney disease with or without hyperuricemia.